86 related articles for article (PubMed ID: 706881)
1. [Clinical-pathological relationships of potenially malignant cystadenomas of the ovaries].
Gáti E; Töttössy B; Sugár J
Zentralbl Gynakol; 1978; 100(15):978-84. PubMed ID: 706881
[TBL] [Abstract][Full Text] [Related]
2. [Serous and mucinous ovarian cystadenomas at the limit of malignancy].
Chenevart P; Gloor E
Schweiz Med Wochenschr; 1980 Apr; 110(14):531-9. PubMed ID: 7375903
[TBL] [Abstract][Full Text] [Related]
3. Serous and seromucinous infantile ovarian cystadenomas--a study of 42 cases.
Massicot R; Rousseau V; Darwish AA; Sauvat F; Jaubert F; Nihoul-Fékété C
Eur J Obstet Gynecol Reprod Biol; 2009 Jan; 142(1):64-7. PubMed ID: 18996636
[TBL] [Abstract][Full Text] [Related]
4. [Serous borderline ovarian tumors].
Zipprich K; Albrecht G; Canzler E
Zentralbl Gynakol; 1985; 107(3):159-68. PubMed ID: 3984570
[TBL] [Abstract][Full Text] [Related]
5. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
6. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
[TBL] [Abstract][Full Text] [Related]
7. Pathology of mucinous ovarian cystadenomas. I. Argyrophil and argentaffin cells and epithelial mucosubstances.
Klemi PJ
Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):465-70. PubMed ID: 716907
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between malignant transformation of ovarian mucinous cystadenoma and intestinal epithelial metaplasia].
Zhong CQ
Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):134-6. PubMed ID: 2555075
[TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
Devaney K; Goodman ZD; Ishak KG
Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
[TBL] [Abstract][Full Text] [Related]
10. Borderline epithelial tumours of the ovary--a retrospective analysis of 31 cases.
Kane SV; Bharadwaj R; Tongaonkar HB
Indian J Cancer; 1999 Mar; 36(1):18-31. PubMed ID: 10810551
[TBL] [Abstract][Full Text] [Related]
11. Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR.
Okamoto Y; Tanaka YO; Tsunoda H; Yoshikawa H; Minami M
J Magn Reson Imaging; 2007 Jul; 26(1):94-9. PubMed ID: 17659568
[TBL] [Abstract][Full Text] [Related]
12. [Low grade malignant ovarian carcinomas. A retrospective study of 132 cases].
Randrianjafisamindrakotroka NS; Hedelin G; Philippe E; Schaffer P
J Gynecol Obstet Biol Reprod (Paris); 1992; 21(7):761-7. PubMed ID: 1469230
[TBL] [Abstract][Full Text] [Related]
13. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
14. Ovarian tumours: a study of 282 cases.
Pilli GS; Suneeta KP; Dhaded AV; Yenni VV
J Indian Med Assoc; 2002 Jul; 100(7):420, 423-4, 447. PubMed ID: 12674165
[TBL] [Abstract][Full Text] [Related]
15. Pattern of ovarian tumours among Malaysian women at General Hospital, Kuala Lumpur.
Thanikasalam K; Ho CM; Adeed N; Shahidan MN; Azizah WK
Med J Malaysia; 1992 Jun; 47(2):139-46. PubMed ID: 1337368
[TBL] [Abstract][Full Text] [Related]
16. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
Evans MF; McDicken IW; Herrington CS
J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
[TBL] [Abstract][Full Text] [Related]
17. MRI appearances of borderline ovarian tumours.
Bent CL; Sahdev A; Rockall AG; Singh N; Sohaib SA; Reznek RH
Clin Radiol; 2009 Apr; 64(4):430-8. PubMed ID: 19264189
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia.
Kalir T; Wang BY; Goldfischer M; Haber RS; Reder I; Demopoulos R; Cohen CJ; Burstein DE
Cancer; 2002 Feb; 94(4):1078-82. PubMed ID: 11920478
[TBL] [Abstract][Full Text] [Related]
19. Zollinger-Ellison syndrome due to a borderline mucinous cystadenoma of the ovary.
Garcia-Villanueva M; Badia Figuerola N; Ruiz del Arbol L; Hernandez Ortiz MJ
Obstet Gynecol; 1990 Mar; 75(3 Pt 2):549-52. PubMed ID: 2304735
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
